SCHEMBL25926342

SCHEMBL25926342

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3oc3cc(-c5ccc6oc7ccc(-n8c9ccccc9c9ccccc98)cc7c6c5)ccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.36
PRKDC P78527 2/20 0.36
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
PTPRF P10586 6/20 0.33
PTPN2 P17706 6/20 0.33
PTPN1 P18031 6/20 0.33
MAPT P10636 3/20 0.32
KDM4E B2RXH2 2/20 0.32
TSHR P16473 2/20 0.32
CHEK2 O96017 1/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALDH1A1 P00352 2/20 0.31
HPGD P15428 1/20 0.31
PTGER4 P35408 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25926366 1.00 ALOX5 (0.36) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL25926331 0.99 ALOX5 (0.37) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL24232395 0.98 ALOX5 (0.36) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL25926338 0.98 ALOX5 (0.36) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL25458461 0.97 PRKDC (0.35) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL26024367 0.97 ALOX5 (0.38) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL24215953 0.97 ALOX5 (0.39) ALOX5PRKDCPTPRFPTPN2PTPN1
SCHEMBL21668798 0.97 ALOX5 (0.39) ALOX5PRKDCPTPRFPTPN2PTPN1
SCHEMBL25926376 0.97 ALOX5 (0.37) ALOX5PRKDCPIM1CSNK2A2CSNK2B
SCHEMBL25458396 0.96 PRKDC (0.34) ALOX5PRKDCPIM1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 ALOX5 959/4885PRKDC 3471/4885PIM1 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.